Titel

Merkliste
1 Ergebnisse

Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivoluma..:

André, T ; Tougeron, D ; Piessen, G...
info:eu-repo/semantics/altIdentifier/doi/10.1200/JCO.22.00686. , 2023

RT Journal
T1 <Title>Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftccsdartic:oai:HAL:hal-03975142v1&Exemplar=1&LAN=DE
				
A1 André, T
A1 Tougeron, D
A1 Piessen, G
A1 de La Fouchardière, C
A1 Louvet, C
A1 Adenis, A
A1 Jary, M
A1 Tournigand, C
A1 Aparicio, T
A1 Desrame, J
A1 Lievre, A
A1 Garcia-Larnicol, M.-L
A1 Pudlarz, T
A1 Cohen, R
A1 Memmi, S
A1 Vernerey, D
A1 Henriques, J
A1 Lefevre, J. H
A1 Svrcek, M
PB HAL CCSD; American Society of Clinical Oncology
YR 2023
K1 antineoplastic agent
K1 ipilimumab
K1 nivolumab
K1 adenocarcinoma
K1 aged
K1 clinical trial
K1 gastroesophageal junction
K1 genetics
K1 human
K1 microsatellite instability
K1 mismatch repair
K1 neoadjuvant therapy
K1 pathology
K1 phase 2 clinical trial
K1 stomach tumor
K1 tumor recurrence
K1 Antineoplastic Combined Chemotherapy Protocols
K1 DNA Mismatch Repair
K1 Esophagogastric Junction
K1 Humans
K1 Neoplasm Recurrence
K1 Local
K1 Stomach Neoplasms
K1 [SDV.CAN]Life Sciences [q-bio]/Cancer
JF info:eu-repo/semantics/altIdentifier/doi/10.1200/JCO.22.00686
LK http://dx.doi.org/https://hal.science/hal-03975142
DO https://hal.science/hal-03975142
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)